CorMedix Company Profile (NYSEMKT:CRMD)

About CorMedix

CorMedix logoCorMedix Inc. is a commercial pharmaceutical and medical device company. The Company in-licenses, develops and commercializes prophylactic and therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company has in-licensed the rights to develop and commercialize its product candidate, CRMD003 (Neutrolin), which addresses market opportunities in the instances in which a central venous catheter is used, such as hemodialysis, intensive care units, oncology, and patients receiving total parenteral nutrition, intravenous (IV) hydration, and/or IV medications. Neutrolin is an anti-infective solution for the prevention of catheter-related infections and thrombosis in the central venous catheter markets, such as dialysis, critical care and oncology. Neutrolin is a broad-spectrum antimicrobial/antifungal and anticoagulant combination that is active against common microbes, including antibiotic-resistant strains, and may prevent biofilm formation.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NYSEMKT
  • Symbol: CRMD
  • CUSIP:
Key Metrics:
  • Previous Close: $2.76
  • 50 Day Moving Average: $1.92
  • 200 Day Moving Average: $2.45
  • 52-Week Range: $1.15 - $4.54
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -5.31
  • P/E Growth: 0.00
  • Market Cap: $102.64M
  • Outstanding Shares: 37,187,000
  • Beta: 0.24
Additional Links:
Companies Related to CorMedix:

Analyst Ratings

Consensus Ratings for CorMedix (NYSEMKT:CRMD) (?)
Ratings Breakdown: 1 Hold Rating, 3 Buy Ratings
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $5.63

Analysts' Ratings History for CorMedix (NYSEMKT:CRMD)
Show:
DateFirmActionRatingPrice TargetDetails
5/16/2016FBR & CoReiterated RatingBuyView Rating Details
3/17/2016Rodman & RenshawBoost Price TargetBuy$6.50 -> $7.50View Rating Details
11/16/2015Roth CapitalLower Price TargetNeutral$2.75 -> $2.50View Rating Details
11/12/2015HC WainwrightInitiated CoverageBuy$6.50View Rating Details
(Data available from 9/24/2014 forward)

Earnings

Earnings History for CorMedix (NYSEMKT:CRMD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/5/2016Q216($0.11)($0.13)$119.97 million$16.51 millionViewN/AView Earnings Details
5/5/2016Q1($0.09)($0.12)ViewN/AView Earnings Details
3/16/2015($0.12)($0.09)ViewN/AView Earnings Details
11/17/2014($0.09)($0.09)ViewN/AView Earnings Details
8/20/2014($0.13)($0.26)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for CorMedix (NYSEMKT:CRMD)
Current Year EPS Consensus Estimate: $-0.57 EPS
Next Year EPS Consensus Estimate: $-0.52 EPS

Dividends

Dividend History for CorMedix (NYSEMKT:CRMD)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for CorMedix (NYSEMKT:CRMD)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/22/2016Janet DillioneDirectorBuy15,000$2.66$39,900.00View SEC Filing  
8/25/2016Taunia MarkvickaDirectorBuy18,600$1.65$30,690.00View SEC Filing  
8/19/2016Cora M TellezDirectorBuy12,500$1.73$21,625.00View SEC Filing  
6/21/2016Antony PfaffleInsiderSell29,657$2.14$63,465.98View SEC Filing  
6/20/2016Antony PfaffleInsiderSell10,000$2.16$21,600.00View SEC Filing  
6/15/2016Antony PfaffleInsiderSell4,900$2.21$10,829.00View SEC Filing  
6/13/2016Antony PfaffleInsiderSell5,443$2.27$12,355.61View SEC Filing  
6/9/2016Antony PfaffleInsiderSell10,000$2.38$23,800.00View SEC Filing  
6/8/2016Janet DillioneDirectorBuy3,738$2.67$9,980.46View SEC Filing  
6/3/2016Matthew DuffyDirectorSell46,106$2.73$125,869.38View SEC Filing  
5/31/2016Steven W LefkowitzDirectorSell50,000$2.88$144,000.00View SEC Filing  
5/25/2016Cora M TellezDirectorBuy8,600$2.90$24,940.00View SEC Filing  
5/24/2016Antony PfaffleInsiderSell12,700$2.73$34,671.00View SEC Filing  
5/24/2016Antony PfaffleInsiderSell12,700$2.73$34,671.00View SEC Filing  
5/23/2016Antony PfaffleInsiderSell15,000$2.89$43,350.00View SEC Filing  
5/23/2016Steven W LefkowitzDirectorSell30,000$2.93$87,900.00View SEC Filing  
5/19/2016Antony PfaffleInsiderSell12,300$2.82$34,686.00View SEC Filing  
5/16/2016Antony PfaffleInsiderSell60,000$2.68$160,800.00View SEC Filing  
6/30/2015Randy MilbyCEOBuy1,610$3.88$6,246.80View SEC Filing  
6/23/2015Taunia MarkvickaDirectorBuy4,000$4.81$19,240.00View SEC Filing  
6/15/2015Randy MilbyCEOBuy1,245$5.02$6,249.90View SEC Filing  
6/4/2015Matthew DuffyDirectorSell30,000$6.48$194,400.00View SEC Filing  
5/29/2015Randy MilbyCEOBuy1,026$6.09$6,248.34View SEC Filing  
2/27/2015Randy MilbyCEOBuy1,211$5.16$6,248.76View SEC Filing  
2/13/2015Randy MilbyCEOBuy1,911$3.27$6,248.97View SEC Filing  
1/30/2015Randy MilbyCEOBuy2,016$3.10$6,249.60View SEC Filing  
12/15/2014Randy MilbyCEOBuy4,734$1.32$6,248.88View SEC Filing  
11/28/2014Randy MilbyCEOBuy4,464$1.40$6,249.60View SEC Filing  
11/14/2014Cora M TellezDirectorBuy11,086$1.52$16,850.72View SEC Filing  
11/14/2014Randy MilbyCEOBuy4,111$1.52$6,248.72View SEC Filing  
10/31/2014Randy MilbyCEOBuy3,434$1.82$6,249.88View SEC Filing  
9/30/2014Randy MilbyCEOBuy3,324$1.88$6,249.12View SEC Filing  
9/15/2014Randy MilbyCEOBuy3,654$1.71$6,248.34View SEC Filing  
8/29/2014Randy MilbyCEOBuy3,125$2.00$6,250.00View SEC Filing  
8/15/2014Randy MilbyCEOBuy3,140$1.99$6,248.60View SEC Filing  
7/31/2014Randy MilbyCEOBuy6,250$2.00$12,500.00View SEC Filing  
6/30/2014Randy MilbyCEOBuy2,732$1.83$4,999.56View SEC Filing  
12/13/2013Steven W LefkowitzInsiderBuy18,000$0.78$14,040.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for CorMedix (NYSEMKT:CRMD)
DateHeadline
News IconKeen Investors Find News on CorMedix, Inc. (:CRMD) - Duncan Research (NYSEMKT:CRMD)
www.duncanindependent.com - September 24 at 9:06 AM
4-traders.com logoCorMedix Inc. : to Present at Multiple Investor and Industry Conferences (NYSEMKT:CRMD)
www.4-traders.com - September 21 at 4:58 PM
News IconCorMedix Inc. (NYSEMKT:CRMD): That’s How Our Subscribers Made 50% In One Week Swing Trading Quickly (NYSEMKT:CRMD)
www.marketnewscall.com - September 21 at 4:58 PM
News IconCorMedix Inc. to Present at Multiple Investor and Industry Conferences - Yahoo News (NYSEMKT:CRMD)
www.yahoo.com - September 21 at 8:39 AM
News IconPenny Stock Investors Take an Interest in CorMedix, Inc. (:CRMD) - Duncan Research (NYSEMKT:CRMD)
www.duncanindependent.com - September 21 at 8:39 AM
News IconTime To Put On The Watch List? - CorMedix (NYSEMKT:CRMD), PTC Therapeutics (NASDAQ:PTCT) - The Voice Registrar (NYSEMKT:CRMD)
voiceregistrar.com - September 21 at 8:39 AM
News IconUnder the Microscope: Getting a Closer Look at Shares of CorMedix, Inc. (:CRMD) - Duncan Research (NYSEMKT:CRMD)
www.duncanindependent.com - September 20 at 10:13 AM
News Icon2 Sizzling Hot Biotechnology Stocks: BioMarin Pharmaceutical Inc. (BMRN), CorMedix, Inc. (CRMD) - The Independent Republic (NYSEMKT:CRMD)
theindependentrepublic.com - September 20 at 10:13 AM
finance.yahoo.com logoCorMedix Inc. to Present at Multiple Investor and Industry Conferences (NYSEMKT:CRMD)
finance.yahoo.com - September 20 at 10:13 AM
News IconCorMedix, Inc. Announces Signing of an Agreement with POETIC (Pediatric Oncology Experimental Therapeutics ... - Yahoo Sports (NYSEMKT:CRMD)
sports.yahoo.com - September 17 at 9:09 AM
News IconKeen Investors Seek Information on CorMedix, Inc. (:CRMD) - Duncan Research (NYSEMKT:CRMD)
www.duncanindependent.com - September 17 at 9:09 AM
4-traders.com logoCORMEDIX INC. : Other Events, Financial Statements and Exhibits (form 8-K) (NYSEMKT:CRMD)
www.4-traders.com - September 16 at 4:18 PM
News IconCorMedix Inc. (NYSEMKT:CRMD) Pivots To An Intriguing Oncology Play (NYSEMKT:CRMD)
streetregister.com - September 16 at 4:18 PM
News IconStock Update, a Closer Look at CorMedix, Inc. (:CRMD) - Duncan Research (NYSEMKT:CRMD)
www.duncanindependent.com - September 16 at 8:03 AM
News IconActive biotech company shares in the news: CorMedix, Inc. (NYSEMKT:CRMD), Achillion Pharmaceuticals, Inc ... - The Voice Registrar (NYSEMKT:CRMD)
voiceregistrar.com - September 16 at 8:03 AM
News IconCorMedix Inc. (NYSEMKT:CRMD) Pivots To An Intriguing Oncology Play - Street Register (NYSEMKT:CRMD)
streetregister.com - September 16 at 8:03 AM
finance.yahoo.com logoCorMedix, Inc. Announces Signing of an Agreement with POETIC (Pediatric Oncology Experimental Therapeutics Investigators Consortium), to Develop CRMD-005, a Proprietary Formulation of Taurolidine, for Rare Orphan Pediatric Tumors (NYSEMKT:CRMD)
finance.yahoo.com - September 15 at 9:34 AM
News IconPenny Stock Investors Highly Curious in Shares of CorMedix, Inc. (:CRMD) - Duncan Research (NYSEMKT:CRMD)
www.duncanindependent.com - September 14 at 9:39 PM
News IconKeen Investors Narrowing Their Focus on CorMedix, Inc. (:CRMD) - Duncan Research (NYSEMKT:CRMD)
www.duncanindependent.com - September 14 at 9:39 PM
benzinga.com logo10 Biggest Mid-Day Gainers For Tuesday - Benzinga (NYSEMKT:CRMD)
www.benzinga.com - September 14 at 9:38 PM
News IconCorMedix Inc. (NYSEMKT:CRMD) Trading Higher on Neutrolin Clinical Trials - Journal Transcript (NYSEMKT:CRMD)
www.journaltranscript.com - September 14 at 9:38 PM
News IconTrading Update – Increased Volatility Noted on Shares of CorMedix, Inc. (:CRMD) - National Daily Press (NYSEMKT:CRMD)
www.nationaldailypress.com - September 10 at 4:09 PM
News IconStock Showing Gains in Afternoon Trading: CorMedix, Inc. (:CRMD) - National Daily Press (NYSEMKT:CRMD)
www.nationaldailypress.com - September 10 at 4:09 PM
capitalcube.com logoETF’s with exposure to CorMedix, Inc. : September 8, 2016 (NYSEMKT:CRMD)
www.capitalcube.com - September 8 at 4:17 PM
finance.yahoo.com logoCorMedix Inc. to Present at 2016 Rodman & Renshaw 18th Annual Global Investment Conference (NYSEMKT:CRMD)
finance.yahoo.com - September 6 at 9:18 AM
News IconDevelopment of CorMedix, Inc.’s (CRMD) Bloodstream Infection Therapy on Pace for Regulatory Approval (NYSEMKT:CRMD)
missionir.com - September 3 at 9:02 AM
News IconStock Tracking Lower for the Quarter: CorMedix, Inc. (:CRMD) - Post News (NYSEMKT:CRMD)
www.kentuckypostnews.com - August 20 at 4:24 PM
News IconShares Dropping Down in Session: CorMedix, Inc. (:CRMD) - Post News (NYSEMKT:CRMD)
www.kentuckypostnews.com - August 18 at 4:28 PM
News IconCorMedix, Inc.'s (CRMD): Stock Buzz - Hot Stocks Point (NYSEMKT:CRMD)
www.hotstockspoint.com - August 18 at 4:28 PM
finance.yahoo.com logoCorMedix Inc. Invited to Present at Two Upcoming Scientific Conferences (NYSEMKT:CRMD)
finance.yahoo.com - August 16 at 8:16 AM
capitalcube.com logoETF’s with exposure to CorMedix, Inc. : August 12, 2016 (NYSEMKT:CRMD)
www.capitalcube.com - August 12 at 4:26 PM
finance.yahoo.com logoCorMedix (CRMD) Shows Strength: Stock Moves Up 24.8% (NYSEMKT:CRMD)
finance.yahoo.com - August 12 at 10:31 AM
capitalcube.com logoCorMedix, Inc. :CRMD-US: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016 (NYSEMKT:CRMD)
www.capitalcube.com - August 9 at 5:24 PM
cnbc.com logoCorMedix reports 2Q loss (NYSEMKT:CRMD)
www.cnbc.com - August 5 at 11:14 AM
marketwired.com logoCorMedix Inc. Reports Second Quarter 2016 Financial Results and Provides Business Updates (NYSEMKT:CRMD)
www.marketwired.com - August 5 at 11:14 AM
finance.yahoo.com logoCorMedix Inc. to Report Second Quarter 2016 Financial Results (NYSEMKT:CRMD)
finance.yahoo.com - August 2 at 9:13 AM
News IconStock Moving Lower for the Month; Investor Update on CorMedix, Inc. (:CRMD) - Engelwood Daily (NYSEMKT:CRMD)
www.engelwooddaily.com - July 20 at 11:45 PM
fiscalstandard.com logoCorMedix Inc (CRMD) Current Analyst Ratings - Fiscal Standard (NYSEMKT:CRMD)
www.fiscalstandard.com - July 20 at 10:50 AM
kcregister.com logoMorning Alert: Helios and Matheson Analytics Inc. (NASDAQ:HMNY), CorMedix, Inc. (NYSEMKT:CRMD), Bank of ... - KC Register (NYSEMKT:CRMD)
www.kcregister.com - July 19 at 9:45 PM
News IconHeightened Volatility Spotted on Shares of: CorMedix, Inc. (:CRMD) - Engelwood Daily (NYSEMKT:CRMD)
www.engelwooddaily.com - July 19 at 9:45 PM
prnewswire.com logoCorMedix Inc. Presentation Now Available for On-Demand Viewing - PR Newswire (press release) (NYSEMKT:CRMD)
www.prnewswire.com - July 18 at 4:35 PM
finance.yahoo.com logoCorMedix Inc. Presentation Now Available for On-Demand Viewing (NYSEMKT:CRMD)
finance.yahoo.com - July 18 at 8:30 AM
fiscalstandard.com logoCorMedix Inc (CRMD) Broker Price Targets For The Coming Week - Fiscal Standard (NYSEMKT:CRMD)
www.fiscalstandard.com - July 17 at 4:11 PM
News IconShares Moving Down on the Week: CorMedix, Inc. (:CRMD) - Engelwood Daily (NYSEMKT:CRMD)
www.engelwooddaily.com - July 16 at 4:20 PM
News IconShares Experiencing a Downtrend: CorMedix, Inc. (:CRMD) - TGP (NYSEMKT:CRMD)
telanaganapress.com - July 16 at 6:07 AM
news.cmlviz.com logoCorMedix Inc Stock Momentum Hits Weakness - CML News (NYSEMKT:CRMD)
news.cmlviz.com - July 15 at 3:26 PM
News IconCormedix Incorporated (NYSEMKT:CRMD) Shorts Decreased by 3.61% After Short Covering - Press Telegraph (NYSEMKT:CRMD)
presstelegraph.com - July 14 at 4:38 PM
News IconCormedix Inc (NYSEMKT:CRMD) Institutional Investors Sentiment Index Up in Q1 2016 - Consumer Eagle (NYSEMKT:CRMD)
www.consumereagle.com - July 14 at 4:38 PM
news.cmlviz.com logoOption Market: CorMedix Inc Risk Hits An Extreme High - CML News (NYSEMKT:CRMD)
news.cmlviz.com - July 14 at 8:19 AM
News IconInvestor Update - Shares Lower in Session: CorMedix, Inc. (:CRMD) - Telanagana Press (NYSEMKT:CRMD)
telanaganapress.com - July 13 at 4:30 PM

Social


Last Updated on 9/24/2016 by MarketBeat.com Staff